London (PAÂ Media/dpa) – Scientists have grown a realistic human lens from stem cells for the first time which could potentially pave the way for new treatments for cataracts …
TDG Syndication
-
-
By David Lawder HOUSTON, Nov 4 (Reuters) – Democrats' resounding sweep to a majority in Congress gives them a big microphone and spotlight to scrutinize President Donald Trump's …
-
Science and Tech
OpenAI, ready to IPO in 2027, now counts majority of sales from enterprises, Brockman says
By Greg Bensinger NAPA, California, Nov 4 (Reuters) – OpenAI President Greg Brockman said on Wednesday the company now generates the majority of its revenue from enterprise sales …
-
Nov 4 (Reuters) – Pixar Animation Studios said on Wednesday that veteran Jonathan Garson will become president on January 4, replacing Jim Morris, who will step back from …
-
By Nimesh Vora MUMBAI, Nov 5 (Reuters) – The Indian rupee is poised to climb at the open on Thursday after oil prices tumbled on bets that the …
-
Sports
BC Partners drops its bid to relaunch LIV Golf due to lack of player commitments, according to reports
VIDEO SHOWS: ARCHIVE VIDEO PROFILE OF LIV GOLF SHOWS: ST. ALBANS, ENGLAND, UNITED KINGDOM (ARCHIVE – JUNE 7, 2022) (LIV GOLF – Editorial use only. Must on-screen courtesy …
-
By David Lawder HOUSTON, Nov 4 (Reuters) – Democrats' resounding sweep to a majority in Congress gives them a big microphone and spotlight to scrutinize President Donald Trump's …
-
(Corrects to remove reference to specific state results in Goldman Sachs' analysis on data centre outlook in paragraph 14) By Jiaxing Li and Selena Li HONG KONG/LONDON, Nov …
-
Nov 4 (Reuters) – Pixar Animation Studios said on Wednesday that veteran Jonathan Garson will become president on January 4, replacing Jim Morris, who will step back from …
-
World
BRIEF-Hutchmed (China) Says FDA Grants Orphan Drug Designation To Sovleplenib For Autoimmune Hemolytic Anemia
Nov 5 (Reuters) – HUTCHMED (China) Ltd: * FDA GRANTS ORPHAN DRUG DESIGNATION TO SOVLEPLENIB FOR AUTOIMMUNE HEMOLYTIC ANEMIA Further company coverage: (The article has been published through …